Systemic Steroids in Adult Asthma Management

Role in Acute Exacerbations

Systemic corticosteroids are a mandatory component in the treatment of severe asthma exacerbations, with oral prednisone 40-60 mg daily for 5-10 days being the recommended regimen for severe episodes, according to the American College of Chest Physicians 1
The American Thoracic Society recommends that systemic corticosteroids should be administered early in the treatment course, as their anti-inflammatory effects may take 6-12 hours to appear 2
For patients who are seriously ill or vomiting, IV hydrocortisone 200 mg every 6 hours is an appropriate alternative, as suggested by the American College of Chest Physicians 1

The American Thoracic Society/European Respiratory Society defines a severe exacerbation as requiring systemic corticosteroids for at least 3 days 3
For severe exacerbations requiring hospitalization, oral prednisone should be continued until peak expiratory flow (PEF) reaches 70% of predicted or personal best, according to the American College of Chest Physicians 1

Oral systemic corticosteroids are used long-term only for patients with severe persistent asthma (step 6 care) when other treatments have failed, as recommended by the American Academy of Allergy, Asthma, and Immunology 4, 5
In a small minority of patients with severe asthma, corticosteroid tablets may be needed on a regular basis for day-to-day treatment, according to the American Thoracic Society 2

Short-term use of systemic corticosteroids may cause reversible abnormalities in glucose metabolism, increased appetite, fluid retention, weight gain, mood alteration, and hypertension, as reported by the American Academy of Allergy, Asthma, and Immunology 6
Long-term use can lead to adrenal axis suppression, growth suppression, dermal thinning, hypertension, diabetes, Cushing syndrome, cataracts, muscle weakness, and rarely impaired immune function, according to the American Academy of Allergy, Asthma, and Immunology 6

Underestimating the severity of asthma exacerbations, which can lead to inadequate treatment and potentially fatal outcomes, as warned by the American College of Chest Physicians 1
Delaying corticosteroid administration during acute exacerbations, as cautioned by the American College of Chest Physicians 1

Inhaled corticosteroids (ICS) are the most consistently effective long-term control medication for persistent asthma, as recommended by the American Academy of Allergy, Asthma, and Immunology 4, 5
Biomarker-directed treatment approaches (targeting type-2 inflammation) may help reduce the need for systemic corticosteroids in some patients, according to the American Thoracic Society 7

Systemic corticosteroids, like oral prednisone, are recommended for most patients with moderate-to-severe asthma exacerbations because they speed the resolution of airflow obstruction and reduce the rate of post-emergency department relapse, as suggested by the Journal of Allergy and Clinical Immunology 8
Inhaled corticosteroids are the cornerstone of daily anti-inflammatory treatment for persistent asthma and should be continued even during exacerbations requiring oral prednisone, according to the Mayo Clinic Proceedings 9
The Expert Panel recommends oral administration of prednisone, which has been shown to have effects equivalent to those of intravenous methylprednisolone but is less invasive, as stated in the Journal of Allergy and Clinical Immunology 8

Supplemental doses of systemic corticosteroids should be given to patients who regularly take corticosteroids, even if the exacerbation is mild, as recommended by the Journal of Allergy and Clinical Immunology 8
In patients with moderate-to-severe exacerbations, early administration of corticosteroid therapy might reduce the likelihood of hospitalization, according to the Journal of Allergy and Clinical Immunology 8

The combination of oral prednisone with inhaled corticosteroids does not pose significant additional risks beyond those associated with each medication individually, as reported in the Mayo Clinic Proceedings 10, 11
Inhaled corticosteroids do not have the clinically important adverse effects on bone mineral density, cortisol production, and glucose metabolism caused by equivalently effective doses of oral glucocorticoids like prednisone, as stated in the Mayo Clinic Proceedings 11
The critical safety advantage is that inhaled corticosteroids provide local anti-inflammatory effects with minimal systemic absorption compared to oral prednisone, according to the Mayo Clinic Proceedings 11

For asthma exacerbations, a common approach is to add a short course of oral prednisone while continuing the patient's regular inhaled corticosteroid therapy, as suggested by the Journal of Allergy and Clinical Immunology 8

For pregnant patients with asthma, inhaled corticosteroids are preferred over oral corticosteroids due to their better safety profile, but oral prednisone may still be used when necessary for severe exacerbations, as recommended by the Journal of Allergy and Clinical Immunology 12